Diabetes Mellitus Type 2 clinical trials

Explore recruiting diabetes mellitus type 2 clinical trials.

Recruiting diabetes mellitus type 2 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetes Mellitus Type 2 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study comparing exposure of semaglutide and dapagliflozin dosed orally as mono-components versus in a fixed-dose combination

Germany

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A study to test how insulin NNC0471-0119 works in the body in participants with type 2 diabetes when given by an insulin pump.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial

Spain, Austria

Therapeutic use (Phase IV) EU CTIS Study details

An interventional, multi-center, randomized, double blinded, placebo controlled study to investigate semaglutide add-on treatment for metabolic control in antipsychotic-using patients (STABIL-NOR – study)

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

(21839) A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes.

Italy, France, Netherlands, Belgium, Spain, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, double-blind, placebo-controlled study on the efficacy and safety of nicotinamide in patients with liver fibrosis.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Diabetes Mellitus Type 2 trials by city

Diabetes Mellitus Type 2 in Toronto Diabetes Mellitus Type 2 in Vancouver Diabetes Mellitus Type 2 in Montreal Diabetes Mellitus Type 2 in Calgary Diabetes Mellitus Type 2 in Edmonton Diabetes Mellitus Type 2 in Ottawa Diabetes Mellitus Type 2 in Winnipeg Diabetes Mellitus Type 2 in Quebec City Diabetes Mellitus Type 2 in Hamilton Diabetes Mellitus Type 2 in Kitchener Diabetes Mellitus Type 2 in London Diabetes Mellitus Type 2 in Halifax Diabetes Mellitus Type 2 in New York Diabetes Mellitus Type 2 in Los Angeles Diabetes Mellitus Type 2 in Chicago Diabetes Mellitus Type 2 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease